Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 6/2011

01-12-2011 | Gynecologic Oncology

Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignancies

Authors: Friederike Hoellen, Roland Reibke, Katrin Hornemann, Marc Thill, Doerte W. Luedders, Katharina Kelling, Amadeus Hornemann, Michael K. Bohlmann

Published in: Archives of Gynecology and Obstetrics | Issue 6/2011

Login to get access

Abstract

Purpose

In case of non-gynecological solid tumors and hematological malignancies diagnosed during pregnancy, individual diagnostic and treatment options must be established by an interdisciplinary team.

Methods

In part II of the present review we report on diagnostic and therapeutic principles in distinct entities of solid and hematological malignancies.

Results

On the basis of a review of the current literature, clinical guidelines and algorithms have been established for diagnosis and therapy of maternal cancer during pregnancy.

Conclusions

The prognosis of the malignancy and the patient’s informed consent must be taken into consideration when the well-being of the expectant mother is weighed against the well-being of the unborn child in case of maternal cancer during pregnancy.
Literature
1.
Loibl S (2008) New therapeutic options for breast cancer during pregnancy. Breast Care (Basel) 3(3):171–176
2.
Litton JK, Theriault RL, Gonzalez-Angulo AM (2009) Breast cancer diagnosis during pregnancy. Womens Health (Lond Engl) 5(3):243–249
3.
Loibl S et al (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237–246PubMedCrossRef
4.
5.
Schönborn I (2009) Malignant diseases in pregnancy. Gynakol Geburtsmed Gynakol Endokrinol 5(2):114–125
6.
Bon GG et al (2001) Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther 16(3):166–172PubMedCrossRef
7.
Sarandakou A, Protonotariou E, Rizos D (2007) Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci 44(2):151–178PubMedCrossRef
8.
Azim HA Jr, Peccatori FA, Pavlidis N (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 36(2):101–109PubMedCrossRef
9.
10.
Hahn KM et al (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107(6):1219–1226PubMedCrossRef
11.
Azim HA Jr et al (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47(1):74–83PubMedCrossRef
12.
Minsker DH, Manson JM, Peter CP (1993) Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121(2):217–223PubMedCrossRef
13.
14.
O’Meara AT et al (2005) Malignant melanoma in pregnancy. A population-based evaluation. Cancer 103(6):1217–1226PubMedCrossRef
15.
16.
Gottschalk N et al (2009) Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge. Onkologie 32(12):748–751PubMedCrossRef
17.
18.
Hauschild A et al (2008) Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion. Cancer 112(5):982–994PubMedCrossRef
19.
Pages C et al (2010) Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol 162(2):274–281PubMedCrossRef
20.
21.
Ueo H et al (1991) Prognosis in gastric cancer associated with pregnancy. World J Surg 15(2):293–297 (discussion 298)PubMedCrossRef
22.
Bruggmann D et al (2006) Gastric cancer in pregnancy—a case report. Zentralbl Gynakol 128(4):224–228PubMedCrossRef
23.
Kakoza RM et al (2009) Pancreatic adenocarcinoma in the pregnant patient: a case report and literature review. J Gastrointest Surg 13(3):535–541PubMedCrossRef
24.
Ikuta S et al (2008) Large mucinous cystic neoplasm of the pancreas associated with pregnancy. World J Gastroenterol 14(47):7252–7255PubMedCrossRef
25.
Wiseman JE et al (2008) Cystic pancreatic neoplasm in pregnancy: a case report and review of the literature. Arch Surg 143(1):84–86PubMedCrossRef
26.
Hakamada K et al (2008) Anaplastic carcinoma associated with a mucinous cystic neoplasm of the pancreas during pregnancy: report of a case and a review of the literature. World J Gastroenterol 14(1):132–135PubMedCrossRef
27.
Blackbourne LH et al (1997) Pancreatic adenocarcinoma in the pregnant patient: case report and review of the literature. Cancer 79(9):1776–1779PubMedCrossRef
28.
Cobey FC, Salem RR (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187(2):181–191PubMedCrossRef
29.
Yaghoobi M, Koren G, Nulman I (2009) Challenges to diagnosing colorectal cancer during pregnancy. Can Fam Physician 55(9):881–885PubMed
30.
Minter A et al (2005) Colon cancer in pregnancy. Cancer Control 12(3):196–202PubMed
31.
Janssen (2005) Colorectal cancer during pregnancy. Der Gynäkologe 38(2):112–117CrossRef
32.
Bernstein MA, Madoff RD, Caushaj PF (1993) Colon and rectal cancer in pregnancy. Dis Colon Rectum 36(2):172–178PubMedCrossRef
33.
Erkek B et al (2007) Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases. Hepatogastroenterology 54(73):77–80PubMed
34.
Dahling MT et al (2009) Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomes. J Matern Fetal Neonatal Med 22(3):204–211PubMedCrossRef
35.
No authors listed (2010) Chemotherapy of metastatic colorectal cancer. Prescrire Int 19(109): 219–24
36.
Kanate AS, Auber ML, Higa GM (2009) Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer. J Oncol Pharm Pract 15(1):5–8PubMedCrossRef
37.
Gensheimer M et al (2009) Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer Chemother Pharmacol 63(2):371–373PubMedCrossRef
38.
Dessolle L et al (2007) Placental metastases from maternal malignancies: review of the literature. J Gynecol Obstet Biol Reprod (Paris) 36(4):344–353
39.
40.
41.
42.
Kim PT et al (2006) Laparoscopic adrenalectomy for pheochromocytoma in pregnancy. Can J Surg 49(1):62–63PubMed
43.
Lew PS et al (2010) Dilemmas in management of brain tumours in pregnancy. Ann Acad Med Singap 39(1):64–65PubMed
44.
Haas JF, Janisch W, Staneczek W (1986) Newly diagnosed primary intracranial neoplasms in pregnant women: a population-based assessment. J Neurol Neurosurg Psychiatry 49(8):874–880PubMedCrossRef
45.
Sneed PK et al (1995) Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys 32(3):823–830PubMedCrossRef
46.
Magne N et al (2001) Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose. Br J Radiol 74(883):638–641PubMed
47.
48.
Ferlito A et al (1998) Pregnancy and malignant neoplasms of the head and neck. Ann Otol Rhinol Laryngol 107(11 Pt 1):991–998PubMed
49.
Smith LH et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189(4):1128–1135PubMedCrossRef
50.
Vannucchi G et al (2010) Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 162(1):145–151PubMedCrossRef
51.
Vini L et al (1999) Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 140(5):404–406PubMedCrossRef
52.
Parlea L et al (2006) Follicular carcinoma of the thyroid with aggressive metastatic behavior in a pregnant woman: report of a case and review of the literature. Hormones (Athens) 5(4):295–302
53.
Roth LK, Taylor HS (2001) Risks of smoking to reproductive health: assessment of women’s knowledge. Am J Obstet Gynecol 184(5):934–939PubMedCrossRef
54.
55.
Azim HA Jr, Peccatori FA, Pavlidis N (2010) Lung cancer in the pregnant woman: to treat or not to treat, that is the question. Lung Cancer 67(3):251–256PubMedCrossRef
56.
Ardizzoni A et al (2007) Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99(11):847–857PubMedCrossRef
57.
Martin D et al (1997) Rhabdomyosarcoma treated with chemotherapy during the third trimester. Obstet Gynecol 89(5 Pt 2):828–831PubMedCrossRef
58.
Merimsky O et al (1999) Management of cancer in pregnancy: a case of Ewing’s sarcoma of the pelvis in the third trimester. Ann Oncol 10(3):345–350PubMedCrossRef
59.
O’Day MP et al (1994) Orbital rhabdomyosarcoma metastatic to the placenta. Am J Obstet Gynecol 171(5):1382–1383PubMed
60.
Rizack T et al (2009) Management of hematological malignancies during pregnancy. Am J Hematol 84(12):830–841PubMedCrossRef
61.
Pereg D, Koren G, Lishner M (2007) The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Haematologica 92(9):1230–1237PubMedCrossRef
62.
Azim HA Jr, Pavlidis N, Peccatori FA (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev 36(2):110–121PubMedCrossRef
63.
Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2(3):173–177PubMedCrossRef
64.
65.
Conchon M et al (2009) Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol 2:42PubMedCrossRef
66.
Shuhaila A et al (2008) Maternal melanoma with placental metastasis. Singap Med J 49(3):e71–e72
67.
Hoellen F et al (2010) Foetal rhabdomyosarcoma with massive cardiac and placental infiltration associated with intrauterine foetal death. Z Geburtshilfe Neonatol 214(4):167–169PubMedCrossRef
68.
Surbone A, Peccatori F, Pavlidis N (2008) Why is the topic of cancer and pregnancy so important? Why and how to read this book. Recent Results Cancer Res 178:1–2PubMedCrossRef
69.
Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42(2):126–140PubMedCrossRef
70.
Metadata
Title
Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignancies
Authors
Friederike Hoellen
Roland Reibke
Katrin Hornemann
Marc Thill
Doerte W. Luedders
Katharina Kelling
Amadeus Hornemann
Michael K. Bohlmann
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 6/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2059-7

Other articles of this Issue 6/2011

Archives of Gynecology and Obstetrics 6/2011 Go to the issue

General Gynecology

The accuracy of the preoperative diagnosis in women undergoing emergent gynecological laparoscopy for acute abdominal pain

Letter to the Editor

Fatal bilateral subdural haematoma after epidural anaesthesia for pregnancy

Letter to the Editor

Uncommon vascular tumor of the ovary. Primary ovarian epithelioid hemangioendothelioma or vascular sarcomatous transformation in ovarian germ cell tumor?

Gynecologic Oncology

Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line

Materno-Fetal Medicine

Maternal plasma noradrenaline levels at 29 weeks and gestational age at birth

Materno-fetal Medicine

Analyzing the impact of private service on the cesarean section rate in public hospital Thailand